SDZXF (Sandoz Group AG) Short-Term Debt: $603 Mil (As of Dec. 2025)


SDZXF Sandoz Group AG SDZXF
18 GF Score
Price $89.55
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG Short-Term Debt?

Sandoz Group AG SDZXF 18 Short-Term Debt is $603 Mil as of Dec. 2025. GuruFocus rates SDZXF with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Sandoz Group AG's Short-Term Debt for the quarter that ended in Dec. 2025 was $603 Mil.

Sandoz Group AG's quarterly Short-Term Debt declined from Dec. 2024 ($129 Mil) to Jun. 2025 ($125 Mil) but then increased from Jun. 2025 ($125 Mil) to Dec. 2025 ($603 Mil).

Sandoz Group AG's annual Short-Term Debt declined from Dec. 2023 ($269 Mil) to Dec. 2024 ($129 Mil) but then increased from Dec. 2024 ($129 Mil) to Dec. 2025 ($603 Mil).

Sandoz Group AG Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Sandoz Group AG Short-Term Debt Related Terms

Sandoz Group AG Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Short-Term Debt Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Short-Term Debt
184.00 269.00 129.00 603.00

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Short-Term Debt Get a 7-Day Free Trial 269.00 295.00 129.00 125.00 603.00
SDZXF
18GF Score
Sandoz Group AG SDZXF
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $603 Mil mean?
Sandoz Group AG (SDZXF) has a Short-Term Debt of $603 Mil as of Dec. 2025.
Is Sandoz Group AG's Short-Term Debt too high?
Sandoz Group AG's current Short-Term Debt is $603 Mil. Overall, Sandoz Group AG has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Short-Term Debt compare to ZTS and UTHR?
Sandoz Group AG's Short-Term Debt of $603 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Sandoz Group AG's current Short-Term Debt is $603 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (SDZXF) has a current Short-Term Debt of $603 Mil. The current Short-Term Debt is $603 Mil. Sandoz Group AG's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Sandoz Group AG (SDZXF), the current Short-Term Debt is $603 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
18GF Score

Get the complete analysis for SDZXF

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$89.55
Price